We are upgrading the repository! We will continue our upgrade in February 2025 - we have taken a break from the upgrade to open some collections for end-of-semester submission. The MS-GIST Master's Reports, SBE Senior Capstones, and UA Faculty Publications collections are currently open for submission. Please reach out to repository@u.library.arizona.edu with your questions, or if you are a UA affiliate who needs to make content available in another collection.
Affiliation
Department of Aerospace and Mechanical Engineering, University of ArizonaCollege of Sciences, University of Arizona
Department of Molecular and Cellular Biology, University of Arizona
University of Arizona Cancer Center, University of Arizona
Issue Date
2024-01-23Keywords
cancer-associated fibroblasts (CAFs)microfluidics
organ-on-chip
prostate cancer
prostate tumor invasion
stromal fibroblasts
tumor microenvironment
Metadata
Show full item recordPublisher
Frontiers Media SACitation
Jiang L, Khawaja H, Tahsin S, Clarkson TA, Miranti CK and Zohar Y (2024), Microfluidic-based human prostate-cancer-on-chip. Front. Bioeng. Biotechnol. 12:1302223. doi: 10.3389/fbioe.2024.1302223Rights
© 2024 Jiang, Khawaja, Tahsin, Clarkson, Miranti and Zohar. This is an open-access article distributed under the terms of the Creative Commons Attribution License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Lack of adequate models significantly hinders advances in prostate cancer treatment, where resistance to androgen-deprivation therapies and bone metastasis remain as major challenges. Current in vitro models fail to faithfully mimic the complex prostate physiology. In vivo animal models can shed light on the oncogenes involved in prostate cancer development and progression; however, the animal prostate gland is fundamentally different from that of human, and the underlying genetic mechanisms are different. To address this problem, we developed the first in vitro microfluidic human Prostate-Cancer-on-Chip (PCoC) model, where human prostate cancer and stromal fibroblast cells were co-cultivated in two channels separated by a porous membrane under culture medium flow. The established microenvironment enables soluble signaling factors secreted by each culture to locally diffuse through the membrane pores affecting the neighboring culture. We particularly explored the conversion of the stromal fibroblasts into cancer-associated fibroblasts (CAFs) due to the interaction between the 2 cell types. Immunofluorescence microscopy revealed that tumor cells induced CAF biomarkers, αSMA and COL1A1, in stromal fibroblasts. The stromal CAF conversion level was observed to increase along the flow direction in response to diffusion agents, consistent with simulations of solute concentration gradients. The tumor cells also downregulated androgen receptor (AR) expression in stromal fibroblasts, while an adequate level of stromal AR expression is maintained in normal prostate homeostasis. We further investigated tumor invasion into the stroma, an early step in the metastatic cascade, in devices featuring a serpentine channel with orthogonal channel segments overlaying a straight channel and separated by an 8 µm-pore membrane. Both tumor cells and stromal CAFs were observed to cross over into their neighboring channel, and the stroma’s role seemed to be proactive in promoting cell invasion. As control, normal epithelial cells neither induced CAF conversion nor promoted cell invasion. In summary, the developed PCoC model allows spatiotemporal analysis of the tumor-stroma dynamic interactions, due to bi-directional signaling and physical contact, recapitulating tissue-level multicellular responses associated with prostate cancer in vivo. Hence, it can serve as an in vitro model to dissect mechanisms in human prostate cancer development and seek advanced therapeutic strategies. Copyright © 2024 Jiang, Khawaja, Tahsin, Clarkson, Miranti and Zohar.Note
Open access journalISSN
2296-4185Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.3389/fbioe.2024.1302223
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2024 Jiang, Khawaja, Tahsin, Clarkson, Miranti and Zohar. This is an open-access article distributed under the terms of the Creative Commons Attribution License.